Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2009-12-13 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including shares sold and gifted, with dates and transaction types. The content focuses exclusively on personal share transactions by a company director. There is no financial performance data, report publication, or management discussion. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and specific to director share transactions, confirming classification as DIRS.
2009-12-13 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares and stock options before and after the change, nature of the transaction, and dates. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is short and focused solely on director's interest changes, with no financial results or other report content. Therefore, the correct classification is Director's Dealing (DIRS).
2009-12-13 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is described as a 'Daily share buy-back notice' related to on-market buy-back activity. It provides detailed information about the number of shares bought back, total consideration paid, highest and lowest prices paid, and compliance statements. The document is a formal notification to the ASX (Australian Securities Exchange) about the company's share repurchase activity. It does not contain financial statements or broader financial performance data, nor is it an announcement of a report publication. This fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares.
2009-12-09 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, and compliance statements. The document is short (2203 characters) and focuses on reporting share repurchase activity rather than financial results or management commentary. This matches the description of a 'Transaction in Own Shares' filing, which reports company buyback activities. It is not an announcement of a report, nor a full financial report, so it is not RPA or 10-K/IR. Therefore, the correct classification is POS (Transaction in Own Shares).
2009-12-08 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' submitted to the ASX. It details the number of shares bought back, total consideration paid, participation by directors, and compliance statements related to the buy-back. The document is short (2194 characters) and focuses solely on reporting share repurchase activity. It does not contain financial statements or broader financial performance data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buyback activities. Therefore, the correct classification is POS (Transaction in Own Shares).
2009-12-07 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' submitted to the ASX. It details the number of shares bought back, total consideration paid, prices, and compliance statements related to the buy-back. It is a regulatory notice about the company's share repurchase activity, not a full financial report or earnings release. The document length is short (2195 characters) and it provides specific transactional data about share buy-backs. This fits the definition of a 'Transaction in Own Shares' filing, which reports on the company's buyback of its own shares.
2009-12-06 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.